Stage IV Marginal Zone Lymphoma: Clinical Trials

7 trials for Stage IV Marginal Zone Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 withdrawn. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 5, Terminated 1, Withdrawn 1

Follow Stage IV Marginal Zone Lymphoma: new trials by email Literature Review of Stage IV Marginal Zone Lymphoma trials Research Report on Stage IV Marginal Zone Lymphoma

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableWithdrawnRoswell Park Cancer Institute2012-05-012012-07-09
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
bortezomib, filgrastim, autologous hematopoietic stem cell transplantation - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia
Not applicableCompletedBarbara Ann Karmanos Cancer Institute232011-07-012021-05-10
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
palifermin, flow cytometry, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedMartin, Paul62010-09-012014-04-02
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
plerixafor, filgrastim, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableTerminatedFred Hutchinson Cancer Center12010-06-012017-06-28
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Not applicableCompletedRoswell Park Cancer Institute622009-01-142019-11-13
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant
lithium carbonate, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedFred Hutchinson Cancer Center202006-06-012017-03-07
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedFred Hutchinson Cancer Center51999-11-012017-05-24

Narrower conditions

Burkitt Lymphoma (7)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (7)  ·  Lymphoma, B-Cell, Marginal Zone (7)  ·  Lymphoma, Follicular (7)  ·  Lymphoma, Large B-Cell, Diffuse (7)  ·  Lymphoma, Large-Cell, Immunoblastic (7)  ·  Lymphoma, Mantle-Cell (7)  ·  Lymphoma, Non-Hodgkin (7)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (7)  ·  Congenital Abnormalities (6)  ·  Hodgkin Disease (6)  ·  Leukemia, Myeloid, Accelerated Phase (6)  ·  Leukemia, Myeloid, Chronic-Phase (6)  ·  Lymphoma, T-Cell, Cutaneous (6)  ·  Multiple Myeloma (6)

Broader conditions

Chronic Disease (7)  ·  DNA Virus Infections (7)  ·  Disease Attributes (7)  ·  Epstein-Barr Virus Infections (7)  ·  Hematologic Diseases (7)  ·  Hemic and Lymphatic Diseases (7)  ·  Herpesviridae Infections (7)  ·  Immune System Diseases (7)  ·  Immunoproliferative Disorders (7)  ·  Infections (7)  ·  Leukemia, B-Cell (7)  ·  Leukemia, Lymphoid (7)  ·  Lymphatic Diseases (7)  ·  Lymphoma, B-Cell (7)  ·  Lymphoproliferative Disorders (7)

Interventions

Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Whole-Body Irradiation (2)  ·  fludarabine phosphate (2)  ·  Antilymphocyte Serum (1)  ·  Bortezomib (1)  ·  Cyclosporine (1)  ·  Fibroblast Growth Factor 7 (1)  ·  Flow Cytometry (1)  ·  Lithium (1)  ·  Lithium Carbonate (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  Therapeutics (1)

Sponsors

Fred Hutchinson Cancer Center (3)  ·  Roswell Park Cancer Institute (2)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Martin, Paul (1)

Countries

United States (6)

Top investigators

Paul Martin (2)  ·  Ann Woolfrey (1)  ·  Divaya Bhutani, M.D. (1)  ·  George Chen (1)  ·  Philip McCarthy (1)  ·  William Bensinger (1)

Results publications

PMID 18698002, PMID 28817727

NIH funding

P01CA018029 (1), P30CA015704 (1), P30CA022453 (1)